# Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse (STAMP: STretch and Myocardial Characterization in Arrhythmogenic Mitral Valve Prolapse)

> **NCT02879825** · NA · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 239 (actual)

## Conditions studied

- Mitral Valve Prolapse

## Interventions

- **DEVICE:** Cardiac MRI

## Key facts

- **NCT ID:** NCT02879825
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-20
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-05-31
- **Target enrollment:** 239 (ACTUAL)
- **Last updated:** 2022-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02879825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02879825, "Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse (STAMP: STretch and Myocardial Characterization in Arrhythmogenic Mitral Valve Prolapse)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02879825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*